Skip to main content
Erschienen in: BMC Nephrology 1/2022

Open Access 01.12.2022 | Case report

A rare case of Immunoglobulin A dominant post-infectious glomerulonephritis (IgA PIGN) in a young patient

verfasst von: A. Saghar, G. Klaus, B. Trutnau, M. Kömhoff, H. J. Gröne, S. Weber

Erschienen in: BMC Nephrology | Ausgabe 1/2022

Abstract

Background

Immunoglobulin A dominant postinfectious glomerulonephritis (IgA PIGN) is a unique medical entity that is rare in the paediatric population. It usually presents with severe renal failure, heavy proteinuria, hypertension, and hypocomplementemia and frequently has an unfavourable prognosis. IgA PIGN generally occurs in association with staphylococcal infections and diabetes mellitus in adult patients. Other pathogens include Escherichia coli and Streptococcus sp. Immunofluorescence studies of kidney biopsy samples show IgA as dominant or codominant antibody.

Case presentation

We encountered a 3-year-old girl with IgA PIGN presenting with acute renal failure, oedema, hypertension, and heavy proteinuria of 7955 mg/g creatinine. Renal biopsy specimens showed diffuse glomerular endocapillary hypercellularity with prominent neutrophil and monocyte infiltration on light microscopy. Strong deposits of IgA and C3 were observed along the glomerular basement membranes and the mesangium by immunofluorescence microscopy, and electron microscopy revealed the presence of subepithelial humps.
The patient was managed with steroid (and probatory antibiotic) therapy and is now undergoing follow-up, with a significant improvement 6 months after the initial presentation (glomerular filtration rate (GFR) and cystatin C clearance rate of 165 ml/min/1.73m2 and 106 ml/min/1.73m2, respectively). No signs of bacterial infection were detectable.

Conclusion

This variant of IgA PIGN must be distinguished from other clinical entities, especially IgA nephropathy (mesangial IgA deposits) and postinfectious glomerulonephritis (C3, IgG and occasional IgM capillary loop deposits with or without mesangial distribution), since patients with IgA PIGN may require steroid treatment in addition to antibiotic therapy. Differential diagnosis should also include C3 glomerulopathy.
IgA PIGN is a recently identified disease entity that generally manifests in adult patients with both IgA and C3 mesangial and glomerular capillary wall deposits. We present a biopsy-proven case of IgA PIGN that manifested in a patient at an exceptionally young age and that has had a good clinical outcome. To the best of our knowledge, this is the youngest IgA PIGN patient reported thus far.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
IgA
Immunoglobulin A
IgA PIGN
immunoglobulin A-dominant postinfectious glomerulonephritis
PIGN
post-infectious glomerulonephritis
LM
light microscopy
IF
immunofluorescence
EM
electron microscopy
BPI
bactericidal/permeability-increasing protein
UPC
urine protein to creatinine

Background

IgA-dominant PIGN is a newly recognized variant of PIGN. It is characterized by proliferative glomerulonephritis seen in light microscopy (LM) with dominant or codominant mesangial and glomerular capillary wall deposits of IgA detected by immunofluorescence (IF) in combination with hump-like deposits obtained by electron microscopy (EM) [1].
The Arkana laboratory database gathered more than 80,000 kidney biopsies and identified about 160 cases of IgA PIGN. Patients were all adults, and the majority were over 40 years of age. About 50% had a comorbidity of diabetes mellitus. Many patients were tested positive for methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-susceptible Staphylococcus aureus (MSSA), and in some of these patients ANCA testing was positive [2, 3]. IF has identified IgA as a dominant or a co-dominant antibody, with a higher potency detected for C3 than IgA. Subepithelial humps and focal necrotizing glomerulonephritis were present in some of the cases [2].
Typical IgA-dominant PIGN has been described in only three children below 18 years of age with a lowest age of 12-years [4, 5]. IgA PIGN typically presents with acute renal failure and severe proteinuria in the majority of cases. Hypocomplementemia is common and can be detected in two-thirds of patients [6].
Conditions predisposing a patient to the develop IgA-dominant PIGN include old age, diabetes, and Staphylococcus aureus infections, furthermore cancer, drug and alcohol abuse [6]. IgA PIGN has been linked to staphylococcal infections but also to infections with other pathogens including E. coli, Enterococcus species and HIV. This type of glomerulonephritis therefore appears to be postinfectious [610]. Pharyngitis has been superseded by skin, urinary or pulmonary infections [6, 1115].
IgA PIGN variants should be differentiated from IgA nephropathy. Features supporting the diagnosis of IgA PIGN over IgA nephropathy include manifestation at an older age, acute kidney failure, a documented staphylococcal infection and low serum complement (C3). Histologic features of IgA PIGN comprise endocapillary hypercellularity, a strong infiltration of neutrophils, a marked deposition of C3 compared to IgA, and characteristic subepithelial humps visible on electron microscopy [1, 2].
The diagnosis of IgA-dominant PIGN is not always easy and the awareness of pediatric IgA-dominant PIGN should improve. This is of importance as it affects the choice of treatment modalities. However, there is no consensus on the management of IgA PIGN. The early use of antibiotics is highly recommended to effectively treat the underlying bacterial infection [16]. However, IgA-dominant PIGN has also been reported without identification of a causal infection [17]. In the presence of progressive glomerulonephritis steroid therapy should be initiated [4, 16]. Despite these recommendations, complete renal recovery was only observed in less than 20% of adult patients [6].

Case presentation

A 3 year and 2-month-old girl presented to the emergency department with a rash on her legs for 1 day and haematuria for 4 days. There was no accompanying fever. She was started on a course of oral cefaclor for presumed urinary tract infection 2 days ago. Urine culture showed no bacterial growth. Eight weeks earlier, the girl had a purulent nail infection and was treated conservatively. One year earlier, the girl had severe streptococcal tonsillitis. The throat swab at that time was positive for streptococci. Her symptoms improved after 10 days of antibiotic therapy. There was no known kidney disease in the family.
Physical examination revealed a hypertensive patient with a rash on her lower extremities but no peri-articular swelling. The rash disappeared on day 4 after admission. Pedal and eyelid oedema were present. No ear, nose or throat (ENT) pathologies, enlarged lymph nodes or ascites were observed.
Clinical examination demonstrated Glasgow Coma Scale (GCS) score 15, pulse 101 beats/min, capillary refill time 1 second, blood pressure 104/63 mmHg (99.P), respiration rate of 24 breaths/min, oxygen saturation (SpO2) 96%, temperature 36.8 °C, weight 16 kg (75.P), and height 96 cm (39.P).
Investigations showed negativity for myeloperoxidase antibodies, lactoferrin antibodies, proteinase 3 antibodies, bactericidal/permeability-increasing protein antibodies, cathepsin G antibodies, antinuclear antibodies and antineutrophil cytoplasmic antibodies and elevated levels of urea, uric acid, creatinine, perinuclear anti-neutrophil cytoplasmic antibodies, elastase antibodies, IgG and anti-streptolysin. The level of C3 was low (0.260 g/l). The results are shown in the supplementary table (Table 1).
Table 1
Laboratory results at hospital admission
 
Value
Range
Unit
Leukocyte
10.6
5.4–13.8
G/L
Erythrocyte
4.4
3.85–5.15
T/L
Haemoglobin
109
107–139
g/L
Haematocrit
0.33
0.33–0.42
L/L
Platelet
360
200–460
G/L
Neutrophils
73
25–68
%
Lymphocytes
18
28–59
%
Eosinophils
0
0.5–5.0
%
Monocytes
8
1.5–9.0
%
Basophils
0
0–1.50
%
Blood sodium
136
134–143
mmol/L
Blood potassium
4.3
3.3–4.6
mmol/L
Blood magnesium
1.1
0.62–0.95
mmol/L
Blood calcium
2.37
2.20–2.70
mmol/L
Blood phosphorus
2.4
1.0–1.95
mmol/L
Blood chloride
103
96–109
mmol/L
Blood glucose
103
60–100
mg/dl
Protein
71
57–80
g/L
Albumin
28
37–51
g/L
CRP
3.8
< 5
mg/L
PT
100
82–121
%
INR
0.91
0.85–1.15
Ratio
aPTT
25
23–38
sec
Fibrinogen
2.8
1.8–5
g/L
LDH
297
105–338
U/L
Bilirubin (total)
0.25
0.2–1
mg/dl
c-ANCAs
negative
< 10
 
p-ANCAs
160
< 10
 
Antistaphylolysin
negative
negative
IU/ml
ASO
532
< 200
IkU/L
Serum IgA
1.6
0.3–1.9
g/l
Serum IgG
15
5.4–13.4
g/L
Serum IgM
0.85
0.52–1.9
g/l
Complement C3
0.260
0.8–1.5
g/l
Complement C4
0.220
0.1–0.4
g/L
Blood urea nitrogen
49,5
5–25
mg/dl
Serum uric acid
8
1.8–5.0
mg/dl
Serum creatinine
0.82
0.26–0.77
mg/dl
CRP C-reactive protein, PT Prothrombin time, INR International normalized ratio, aPTT Activated partial thromboplastin time, LDH Lactate dehydrogenase, c-ANCAs Antineutrophil cytoplasmic antibodies, p-ANCAs Perinuclear antineutrophil cytoplasmic antibodies, ASO Antistreptolysin
Urinalysis: Dipstick tests showed 3+ proteinuria, haematuria, and leukocyturia. The results were negative for nitrite and showed a normal urine pH. A 24-h urine test showed normal creatinine levels and elevated levels of protein(2.8 g/l), protein/g creatinine(7955 mg/g). See (Table 2).
Table 2
24-h Urine test results
 
Value
Range
Unit
Urine volume
730 ml
 
ml/d
Creatinine
35.2
 
mg/dl
Protein
2.8
< 0.05
g/L
Protein/g creatinine
7955
< 70
mg/g
IgG/g creatinine
233
< 9
mg/g
A2 macroglobulin
19
< 5
mg/L
IgG
82
< 7.8
mg/L
Albumin
1920
0–20
mg/L
A1 microglobulin/g creatinine
28
< 14
mg/g
Albumin/creatinine
2500
< 30
mg/g
Renal ultrasound showed bilateral enlarged hyperechogenic kidneys. The volumes were 64 cm3 for the right kidney and 70 cm3 for the left kidney. There was no evidence of any urinary transport disorder. Otherwise, an age- appropriate abdominal sonogram was documented (Fig. 1).
Echocardiography: There was no left ventricular hypertrophy (LVH) or pericardial effusion. The tricuspid aortic valve and coronary outlets were normal. Physiologic regurgitation was observed in the pulmonary and tricuspid valves. There was no aortic or mitral insufficiency.
Renal biopsy was performed. Light microscopy showed 47 glomeruli, out of which seven showed segmental basal membrane rupture with leakage of necrotic fibrinoid material into the extra-capillary space and adjacent alternating strong extra-capillary proliferation. The remaining glomeruli showed significantly increased mesangial and endocapillary hypercellularity, with focal infiltration of the intra-capillary space by neutrophilic granulocytes and monocytes. The peripheral basal membranes were typical, with podocytes with flat cytoplasm. The afferent arterioles were not affected, and Congo red staining was negative (Fig. 2A and B).
Electron microscopy showed glomerular parts with typically structured basement membranes. An increase in mesangial cellularity was observed, along with electron-dense subepithelial humps and mesangial deposits. Endocapillary hypercellularity and granulocytic and monocytic infiltration were prominent (Fig. 2C and D).
Immunofluorescence revealed positive focal segmental mesangial and glomerular basement membrane staining for IgA and complement factor (C1q). The same pattern was observed to a lesser extent for IgG. A positive glomerular basement membrane staining in the form of humps for complement factor C3 was observed. A strong complement factor C3 and Fibrinogen staining was detected in the mesangium. The same pattern was observed to a lesser extent for IgM (Fig. 2E and F).
A causative organism was not identified and based on an initial clinical diagnosis of Henoch-Schoenlein purpura with heavy proteinuria, the girl was initially managed with methylprednisolone 300 mg/m2 i.v for three alternate days, followed by prednisolone p.o. 40 mg/m2. Renal biopsy findings were then consistent with IgA PIGN, and the patient was treated with 10 days of antibiotic therapy consisting of cefuroxime i.v. for 3 days followed by flucloxacillin p.o. for 7 days due to a presumed untreated staphylococcal skin infection (paronychia) 8 weeks prior. Prednisolone 40 mg/m2 p.o. was continued for a total period of 1 week and then weaned over next 6 weeks.
The patient experienced partial renal recovery (decrease in serum creatinine from 0.82 mg/dl to 0.31 mg/dl) and a reduction in nephrotic proteinuria (decline from 7955 mg/g to 782 mg/g creatinine) within 32 days. Her serum C3 level completely normalized on day 25 after admission.
At the 6-month follow-up visit, the patient’s creatinine level had improved to 0.25 mg/dL, with a urine protein to creatinine (UPC) ratio of 132 mg/g.

Discussion and conclusion

IgA PIGN is a rare but increasingly recognized PIGN variant. It has been reported in only 3 children worldwide, the youngest being 12 years old [4, 5].
We here present a 3-year-old child that manifested with nephritic and nephrotic syndrome in the setting of a recent paronychia. She was treated with steroids and antibiotics which was associated with an improvement in kidney function and level of proteinuria. This report raises awareness regarding IgA-dominant PIGN, especially in children. Factors that support this rare diagnosis in this age group include hypocomplementaemia, recent suspected staphylococcal infections and characteristic histological findings in renal biopsy specimens.
IgA dominant PIGN is a recently recognized entity with rising incidence that has to be distinguished from the classical diagnosis of IgA nephropathy on one hand and post-streptococcal PIGN on the other. IgA dominant PIGN and IgA nephropathy share clinical and histological similarities that can mislead in diagnosis, especially if the GN remains undiagnosed for a long time. Satoskar et al. summarized clinical and histological factors that are useful in distinguishing these two disease entities [18, 19]. Leading clinical features that favour IgA PIGN over IgA nephropathy are manifestation at an older age, acute kidney failure, a documented staphylococcal infection and low serum complement (C3). Typical histologic features of IgA PIGN include diffuse endocapillary hypercellularity, marked neutrophil infiltration, enhanced deposition of C3 compared to IgA, and characteristic subepithelial humps visible on electron microscopy [4, 2022]. If several of the above factors are present, IgA dominant PIGN is a likely diagnosis.
Furthermore, IgA nephropathy and IgA PIGN differ in mesangial staining for IgA1 lambda and kappa isoform ratio, which shows a dominance of IgA1 lambda in IgA nephropathy and of IgA1 kappa in IgA PIGN [4, 17, 23].
Unlike classical post-streptococcaI PIGN, which is characterized by C3 deposition, IgA PIGN has a typical IgA deposition [6]. The fact that infection with Staphylococcus spp. can cause either IgA PIGN or acute classic PIGN suggests the existence of additional factors causing renal disease. The type of infection does not completely explain the observed differences in antibodies production. Genetic susceptibility may also play a role [3, 19]. To date, the pathophysiology of IgA dominant PIGN remains unknown to a large extend and some might consider it to be a variation of IgA nephropathy.
Renal biopsy confirmed the diagnosis of IgA PIGN in our patient. Unlike the findings in the study by Nasr et al. [6], in which the subepithelial deposits in cases of IgA PIGN were small and sparse, our findings are therefore more consistent with earlier observations by Haas et al. [4, 24], in that subepithelial deposits were large, numerous, and hump shaped.
To date, there has been no systematic assessment of treatment choices or their effectiveness in the treatment of IgA-dominant PIGN, including steroids [6, 25]. The clinical response is usually favourable when the underlying infection is treated, but in some cases, steroid treatment has been added [79, 20]. Clinical criteria for the use of steroids are not well defined. It has been suggested that steroid therapy should be considered in patients who do not respond to antibiotics alone [26].
In our report, the patient was followed for a short period (< 1 year) and experienced partial recovery from renal failure and persistent proteinuria. Long-term follow-up is needed to assess the progression of the disease. Nasr et al. noted that only 16% of adult IgA-dominant PIGN patients experienced full recovery of renal function (≤1.2 mg/dl), whereas 43% had persistent renal dysfunction, and 41% progressed to end-stage renal disease (ESRD) [6].
In summary, the prognosis of IgA-dominant PIGN is less favourable than that of typical acute post-infectious glomerulonephritis [4, 1214, 20, 22, 27], in the majority of cases, 70 to 80% start with acute kidney injury, proteinuria, haematuria, and hypocomplimentaemia [4, 6, 1214, 20, 22, 27]. Despite the fact that IgA PIGN seems to be a disease without recurrences and exacerbations that characterize primary IgA nephropathy, only less than 20% of adult patients achieve a complete renal recovery. Data on paediatric patients is scarce and it remains to be observed and discussed in future publications whether the renal prognosis in paediatric age group is more favourable than in adults and elderly.

Acknowledgements

MK for performing the renal biopsy and HG for providing the histopathology report.

Declarations

Not applicable.
The featured patient’s parents gave written consent for the publication of their child’s personal or clinical details along with any identifying images.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Rajakumar V, Noor Mohamed SAK, Kurien AA. IgA dominant postinfectious glomerulonephritis: report of two cases. Indian J Nephrol. 2014;24(3):181–4.CrossRef Rajakumar V, Noor Mohamed SAK, Kurien AA. IgA dominant postinfectious glomerulonephritis: report of two cases. Indian J Nephrol. 2014;24(3):181–4.CrossRef
2.
Zurück zum Zitat Gaut JP, Mueller S, Liapis H. IgA dominant postinfectious glomerulonephritis update: pathology spectrum and disease mechanisms. Diagnostic Histopathol. 2017;23(3):126–32.CrossRef Gaut JP, Mueller S, Liapis H. IgA dominant postinfectious glomerulonephritis update: pathology spectrum and disease mechanisms. Diagnostic Histopathol. 2017;23(3):126–32.CrossRef
3.
Zurück zum Zitat Boils CL, Nasr SH, Walker PD. Update on endocarditis associated glomerulonephritis. Kidney Int. 2015;87:1241–9.CrossRef Boils CL, Nasr SH, Walker PD. Update on endocarditis associated glomerulonephritis. Kidney Int. 2015;87:1241–9.CrossRef
4.
Zurück zum Zitat Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008;39:1309–16.CrossRef Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008;39:1309–16.CrossRef
5.
Zurück zum Zitat Srinivasaraghavan R, Krishnamurthy S, Dubey AK. IgA dominant post-infectious glomerulonephritis in a 12-year-old child. Indian J Pediatr. 2016;83(5):470–2.CrossRef Srinivasaraghavan R, Krishnamurthy S, Dubey AK. IgA dominant post-infectious glomerulonephritis in a 12-year-old child. Indian J Pediatr. 2016;83(5):470–2.CrossRef
6.
Zurück zum Zitat Nasr SH, D'Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011;119(1):c18–25.CrossRef Nasr SH, D'Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011;119(1):c18–25.CrossRef
7.
Zurück zum Zitat Bu R, Li Q, Duan ZY, Wu J, Chen P, Chen XM, et al. Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: a pooled analysis of 78 cases. Am J Nephrol. 2015;41:98–106.CrossRef Bu R, Li Q, Duan ZY, Wu J, Chen P, Chen XM, et al. Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: a pooled analysis of 78 cases. Am J Nephrol. 2015;41:98–106.CrossRef
8.
Zurück zum Zitat Handa T, Kakita H, Tateishi Y, Endo T, Suzuki H, Katayama T, et al. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study. Clin Exp Nephrol. 2018;22:1116–27.CrossRef Handa T, Kakita H, Tateishi Y, Endo T, Suzuki H, Katayama T, et al. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study. Clin Exp Nephrol. 2018;22:1116–27.CrossRef
9.
Zurück zum Zitat Kanno M, Tanaka K, Kimura H, Watanabe K, Hayashi Y, Asahi K, et al. Garland-pattern postinfectious glomerulonephritis with IgA-dominant deposition. CEN Case Rep. 2014;3:56–62.CrossRef Kanno M, Tanaka K, Kimura H, Watanabe K, Hayashi Y, Asahi K, et al. Garland-pattern postinfectious glomerulonephritis with IgA-dominant deposition. CEN Case Rep. 2014;3:56–62.CrossRef
10.
Zurück zum Zitat Mascarenhas R, Fogo AB, Steele RW, Baliga R. IgA-dominant postinfectious glomerulonephritis. Clin Pediatr. 2016;55:873–6.CrossRef Mascarenhas R, Fogo AB, Steele RW, Baliga R. IgA-dominant postinfectious glomerulonephritis. Clin Pediatr. 2016;55:873–6.CrossRef
11.
Zurück zum Zitat Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis: experience with 76 patients and review of the literature. Medicine. 1995;74:63–73.CrossRef Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis: experience with 76 patients and review of the literature. Medicine. 1995;74:63–73.CrossRef
12.
Zurück zum Zitat Koo TY, Kim GH, Park H. Clinicopathologic features of IgA-dominant Postinfectious glomerulonephritis. Korean J Pathol. 2012;46:105–14.CrossRef Koo TY, Kim GH, Park H. Clinicopathologic features of IgA-dominant Postinfectious glomerulonephritis. Korean J Pathol. 2012;46:105–14.CrossRef
13.
Zurück zum Zitat Worawichawong S, Girard L, Trpkov K, Gough JC, Gregson DB, Benediktsson H. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection. Hum Pathol. 2011;42:279–84.CrossRef Worawichawong S, Girard L, Trpkov K, Gough JC, Gregson DB, Benediktsson H. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection. Hum Pathol. 2011;42:279–84.CrossRef
14.
Zurück zum Zitat Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.CrossRef Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.CrossRef
15.
Zurück zum Zitat Handa T, Ono T, Watanabe H, Takeda T, Muso E, Kita T. Glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus infection. Clin Exp Nephrol. 2003;7:247–9.CrossRef Handa T, Ono T, Watanabe H, Takeda T, Muso E, Kita T. Glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus infection. Clin Exp Nephrol. 2003;7:247–9.CrossRef
16.
Zurück zum Zitat Nagaba Y, Hiki Y, Aoyama T, et al. Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulone-phritis. Nephron. 2002;92:297–303.CrossRef Nagaba Y, Hiki Y, Aoyama T, et al. Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulone-phritis. Nephron. 2002;92:297–303.CrossRef
17.
Zurück zum Zitat Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22:187–95.CrossRef Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22:187–95.CrossRef
18.
Zurück zum Zitat Satoskar AA, Nadasdy G, Plaza JA, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.CrossRef Satoskar AA, Nadasdy G, Plaza JA, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.CrossRef
19.
Zurück zum Zitat Satosker AA, Suleiman S, Ayoub I, et al. Staphylococcus infection-associated GN-spectrum of IgA staining and prevalence of ANCA in a single center cohort. Clin J Am Soc Nephrol. 2017;6(12):39–49.CrossRef Satosker AA, Suleiman S, Ayoub I, et al. Staphylococcus infection-associated GN-spectrum of IgA staining and prevalence of ANCA in a single center cohort. Clin J Am Soc Nephrol. 2017;6(12):39–49.CrossRef
20.
Zurück zum Zitat Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen RM, Fein DA, et al. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol. 2003;34:1235–41.CrossRef Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen RM, Fein DA, et al. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol. 2003;34:1235–41.CrossRef
21.
Zurück zum Zitat Nasr SH, Share DS, Vargas MT, D’Agati VD, Markowitz GS. Acute poststaphylococcal glomerulonephritis superimposed on diabetic glomerulosclerosis. Kidney Int. 2007;71:1317–21.CrossRef Nasr SH, Share DS, Vargas MT, D’Agati VD, Markowitz GS. Acute poststaphylococcal glomerulonephritis superimposed on diabetic glomerulosclerosis. Kidney Int. 2007;71:1317–21.CrossRef
22.
Zurück zum Zitat Wen YK, Chen ML. Discrimination between postinfectious IgA-dominant glomerulonephritis and idiopathic IgA nephropathy. Ren Fail. 2010;32:572–7.CrossRef Wen YK, Chen ML. Discrimination between postinfectious IgA-dominant glomerulonephritis and idiopathic IgA nephropathy. Ren Fail. 2010;32:572–7.CrossRef
23.
Zurück zum Zitat Chui SH, Lam CW, Lewis WH, Lai KN. Light-chain ratio of serum IgA1 in IgA nephropathy. J Clin Immunol. 1991;11:219–23.CrossRef Chui SH, Lam CW, Lewis WH, Lai KN. Light-chain ratio of serum IgA1 in IgA nephropathy. J Clin Immunol. 1991;11:219–23.CrossRef
24.
Zurück zum Zitat Elodie MS, Charlotte J. Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study. Diagn Pathol. 2020;15:62.CrossRef Elodie MS, Charlotte J. Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study. Diagn Pathol. 2020;15:62.CrossRef
25.
Zurück zum Zitat Okuyama S, Wakui H, Maki N, Kuroki J, Nishinari T, Asakura K, et al. Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clin Nephrol. 2008;70:344–7.CrossRef Okuyama S, Wakui H, Maki N, Kuroki J, Nishinari T, Asakura K, et al. Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clin Nephrol. 2008;70:344–7.CrossRef
26.
Zurück zum Zitat Gaut JP, Liapis H. IgA dominant post-infectious glomerulonephritis: pathology and insights into disease mechanisms. Diagn Histopathol. 2013;19:175–81.CrossRef Gaut JP, Liapis H. IgA dominant post-infectious glomerulonephritis: pathology and insights into disease mechanisms. Diagn Histopathol. 2013;19:175–81.CrossRef
27.
Zurück zum Zitat Spector DA, Millan J, Zauber N, Burton J. Glomerulonephritis and staphylococcal aureus infections. Clin Nephrol. 1980;14:256–61.PubMed Spector DA, Millan J, Zauber N, Burton J. Glomerulonephritis and staphylococcal aureus infections. Clin Nephrol. 1980;14:256–61.PubMed
Metadaten
Titel
A rare case of Immunoglobulin A dominant post-infectious glomerulonephritis (IgA PIGN) in a young patient
verfasst von
A. Saghar
G. Klaus
B. Trutnau
M. Kömhoff
H. J. Gröne
S. Weber
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Nephrology / Ausgabe 1/2022
Elektronische ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02965-7

Weitere Artikel der Ausgabe 1/2022

BMC Nephrology 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.